Company Description
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.
The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.
It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.
The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors.
It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
| Country | United States |
| Founded | 1992 |
| IPO Date | Aug 13, 2010 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 174 |
| CEO | James Cunniff |
Contact Details
Address: 500 Sixth Avenue NW New Prague, Minnesota 56071 United States | |
| Phone | 952 758 9299 |
| Website | smartvest.com |
Stock Details
| Ticker Symbol | ELMD |
| Exchange | NYSEAMERICAN |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001488917 |
| CUSIP Number | 285409108 |
| ISIN Number | US2854091087 |
| Employer ID | 41-1732920 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| James L. Cunniff | President, Chief Executive Officer and Director |
| Bradley M. Nagel | Chief Financial Officer, Treasurer and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 21, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Nov 18, 2024 | 144 | Filing |
| Nov 18, 2024 | 8-K | Current Report |
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 8-K | Current Report |
| Oct 1, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Oct 1, 2024 | DEF 14A | Other definitive proxy statements |
| Oct 1, 2024 | ARS | Filing |